US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 269 actively recruiting studies with Colorado sites out of 269 registered in total. The busiest research areas in Colorado are Breast Cancer, Aging, Solid Tumor. Leading sponsors running trials in the state include University of Colorado, Denver, Pfizer, AstraZeneca. By stage, Colorado trials break down as Phase 1 (56), Phase 2 (76), Phase 3 (78), Phase 4 (12).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
269
Recruiting Now
269
← Back to US Map
Top Conditions in Colorado
Breast Cancer (5)Aging (4)Solid Tumor (4)Multiple Myeloma (4)Non-Small Cell Lung Cancer (4)Pancreatic Cancer (3)Solid Tumor, Adult (3)Colorectal Neoplasms (3)Urothelial Carcinoma (3)Type 1 Diabetes (3)Cardiovascular Diseases (3)Overweight (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 269 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 269. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Aging, Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT06324201 N/A
Recruiting
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use i...
Condition
Paroxysmal Atrial Fibrillation
Enrollment
250 pts
Location
United States
Sponsor
Heart Rhythm Clinical and Rese
View Trial →
NCT04408430 N/A
Recruiting
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Condition
Mitral Annular Calcification
Enrollment
210 pts
Location
United States, Mexico
Sponsor
Mayra Guerrero
View Trial →
NCT06576271 Phase 1
Recruiting
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE...
Condition
Systemic Lupus Erythematosus
Enrollment
142 pts
Location
United States, Argentina, Brazil
Sponsor
GlaxoSmithKline
View Trial →
NCT07422675 Phase 1
Recruiting
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
Condition
PARKINSON DISEASE (Disorder)
Enrollment
40 pts
Location
United States, Australia
Sponsor
Serina Therapeutics
View Trial →
NCT05915299 N/A
Recruiting
US National OCS Heart Perfusion (OHP) Registry
Condition
Heart Transplant
Enrollment
100,000 pts
Location
United States
Sponsor
TransMedics
View Trial →
NCT04176198 Phase 1, Phase 2
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Condition
Myelofibrosis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Sumitomo Pharma America, Inc.
View Trial →
NCT05885698 N/A
Recruiting
MYLUNG Consortium Part 3: Observational Study
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
7,500 pts
Location
United States
Sponsor
US Oncology Research
View Trial →
NCT06055608 Phase 2
Recruiting
Advancing Transplantation Outcomes in Children
Condition
Kidney Transplant
Enrollment
200 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT06059638 N/A
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Condition
Hypertension
Enrollment
316 pts
Location
United States, Australia, Belgium
Sponsor
Orchestra BioMed, Inc
View Trial →
NCT07477691 Phase 4
Recruiting
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
Condition
Phenylketonuria
Enrollment
12 pts
Location
United States
Sponsor
BioMarin Pharmaceutical
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05868226 Phase 1, Phase 2
Recruiting
PRE-ISPY Phase I/II Oncology Platform Program
Condition
HER2-positive Breast Cancer
Enrollment
280 pts
Location
United States
Sponsor
QuantumLeap Healthcare Collabo
View Trial →
NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
View Trial →
NCT07218926 Phase 3
Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastr...
Condition
Gastrointestinal Neoplasms
Enrollment
450 pts
Location
United States, Australia, Belgium
Sponsor
GlaxoSmithKline
View Trial →
NCT06311708 N/A
Recruiting
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Ad...
Condition
Arrhythmogenic Right Ventricular Cardiomyopathy
Enrollment
200 pts
Location
United States, France, Germany
Sponsor
Tenaya Therapeutics
View Trial →
NCT06095089 Phase 1
Recruiting
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Condition
Prostatic Neoplasms
Enrollment
355 pts
Location
United States, Australia, China
Sponsor
Janssen Research & Development
View Trial →
NCT07705035 Phase 1
Recruiting
DBC-664 in Adult Patients With Solid Tumors
Condition
Malignant Germ Cell Tumor
Enrollment
210 pts
Location
United States
Sponsor
Duboce Biopharmaceuticals, Inc
View Trial →
NCT06307795 Phase 1
Recruiting
A Study to Investigate ANS014004 in Participants With Locally Advanced or Metast...
Condition
Locally Advanced or Metastatic Solid Tumors
Enrollment
63 pts
Location
United States, Canada, China
Sponsor
Avistone Biotechnology Co., Lt
View Trial →
NCT06667141 Phase 1
Recruiting
Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
Condition
Specific Advanced Solid Tumors
Enrollment
100 pts
Location
United States
Sponsor
Acrivon Therapeutics
View Trial →
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
View Trial →
NCT06477172 N/A
Recruiting
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
Condition
Post Procedural Erythema
Enrollment
500 pts
Location
United States, Canada
Sponsor
Acorn Biolabs Inc.
View Trial →
NCT04731272 Phase 2
Recruiting
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Condition
Cystic Fibrosis
Enrollment
30 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT06526819 Phase 1, Phase 2
Recruiting
SMP-3124LP in Adults With Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
120 pts
Location
United States, Japan
Sponsor
Sumitomo Pharma America, Inc.
View Trial →
NCT05519475 Phase 2
Recruiting
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Dise...
Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Enrollment
120 pts
Location
United States, Japan, Puerto Rico
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06134167 N/A
Recruiting
Transdermal Compress IDE Study
Condition
Prosthesis and Implants
Enrollment
100 pts
Location
United States
Sponsor
Balmoral Medical company
View Trial →
Page 2 of 11 — 269 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology